These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 23889533)

  • 41. Predictors of Red Cell Alloimmunization in Kurdish Multi Transfused Patients with Hemoglobinopathies in Iraq.
    Al-Mousawi MM; Al-Allawi NA; Alnaqshabandi R
    Hemoglobin; 2015; 39(6):423-6. PubMed ID: 26327166
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Intensive red blood cell transfusions and risk of alloimmunization.
    Zalpuri S; Middelburg RA; Schonewille H; de Vooght KM; le Cessie S; van der Bom JG; Zwaginga JJ
    Transfusion; 2014 Feb; 54(2):278-84. PubMed ID: 23782244
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Epidemiologic and clinical characteristics of nontransfusion-dependent thalassemia in the United States.
    Vichinsky E; Cohen A; Thompson AA; Giardina PJ; Lal A; Paley C; Cheng WY; McCormick N; Sasane M; Qiu Y; Kwiatkowski JL
    Pediatr Blood Cancer; 2018 Jul; 65(7):e27067. PubMed ID: 29637688
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Ten-year pattern of red blood cell use in the North of England.
    Tinegate H; Chattree S; Iqbal A; Plews D; Whitehead J; Wallis JP;
    Transfusion; 2013 Mar; 53(3):483-9. PubMed ID: 22803573
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Impact of Red Blood Cell Antigen Matching on Alloimmunization and Transfusion Complications in Patients with Sickle Cell Disease: A Systematic Review.
    Fasano RM; Meyer EK; Branscomb J; White MS; Gibson RW; Eckman JR
    Transfus Med Rev; 2019 Jan; 33(1):12-23. PubMed ID: 30122266
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Lower alloimmunization rates in pediatric sickle cell patients on chronic erythrocytapheresis compared to chronic simple transfusions.
    Wahl SK; Garcia A; Hagar W; Gildengorin G; Quirolo K; Vichinsky E
    Transfusion; 2012 Dec; 52(12):2671-6. PubMed ID: 22519830
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Early occurrence of red blood cell alloimmunization in patients with sickle cell disease.
    Sins JW; Biemond BJ; van den Bersselaar SM; Heijboer H; Rijneveld AW; Cnossen MH; Kerkhoffs JL; van Meurs AH; von Ronnen FB; Zalpuri S; de Rijke YB; Ellen van der Schoot C; de Haas M; van der Bom JG; Fijnvandraat K
    Am J Hematol; 2016 Aug; 91(8):763-9. PubMed ID: 27102719
    [TBL] [Abstract][Full Text] [Related]  

  • 48. How do I incorporate red cell genotyping to improve chronic transfusion therapy?
    Van Buren NL; Gorlin JB; Corby SM; Cassidy S; FritchLilla S; Nelson SC; Westhoff CM
    Transfusion; 2020 Jan; 60(1):16-25. PubMed ID: 31758587
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prevalence and clinical significances of red cell alloimmunization and red cell bound immunoglobulin G in polytransfused patients with thalassemias.
    Thedsawad A; Taka O; Wanachiwanawin W
    Hematology; 2019 Dec; 24(1):208-214. PubMed ID: 30479186
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Blood transfusion: quality and safety issues in thalassemia, basic requirements and new trends.
    Porter J
    Hemoglobin; 2009; 33 Suppl 1():S28-36. PubMed ID: 20001630
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Red Blood Cell Alloimmunization and Autoimmunization in Blood Transfusion-Dependent Sickle Cell Disease and
    Kuriri FA; Ahmed A; Alanazi F; Alhumud F; Ageeli Hakami M; Atiatalla Babiker Ahmed O
    Anemia; 2023; 2023():3239960. PubMed ID: 37152479
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Impact of antigenic exposures and role of molecular blood grouping in enhancing transfusion safety in chronically transfused thalassemics.
    Makroo RN; Agrawal S; Bhatia A; Chowdhry M; Thakur UK
    Asian J Transfus Sci; 2016; 10(2):140-4. PubMed ID: 27605852
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Red cell alloimmunisation in regularly transfused beta thalassemia patients in Pakistan.
    Zaidi U; Borhany M; Ansari S; Parveen S; Boota S; Shamim I; Zahid D; Shamsi T
    Transfus Med; 2015 Apr; 25(2):106-10. PubMed ID: 25870030
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of a transfusion preparation of newly formed red cells and standard washed red cell transfusions in patients with homozygous beta-thalassemia.
    Collins AF; Gonçalves-Dias C; Haddad S; Talbot R; Herst R; Tyler BJ; Zuber E; Blanchette VS; Olivieri NF
    Transfusion; 1994 Jun; 34(6):517-20. PubMed ID: 8023393
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Red blood cell antibodies in thalassemia patients in northern India: risk factors and literature review.
    Elhence P; Solanki A; Verma A
    Indian J Hematol Blood Transfus; 2014 Dec; 30(4):301-8. PubMed ID: 25435732
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The Age of BLood Evaluation (ABLE) randomised controlled trial: description of the UK-funded arm of the international trial, the UK cost-utility analysis and secondary analyses exploring factors associated with health-related quality of life and health-care costs during the 12-month follow-up.
    Walsh TS; Stanworth S; Boyd J; Hope D; Hemmatapour S; Burrows H; Campbell H; Pizzo E; Swart N; Morris S
    Health Technol Assess; 2017 Oct; 21(62):1-118. PubMed ID: 29067906
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical outcome of transfusions with extended red blood cell matching in β-thalassemia patients: A single-center experience.
    Belsito A; Costa D; Signoriello S; Fiorito C; Tartaglione I; Casale M; Perrotta S; Magnussen K; Napoli C
    Transfus Apher Sci; 2019 Feb; 58(1):65-71. PubMed ID: 30591410
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Predictors of red cell alloimmunization in multitransfused Egyptian patients with β-thalassemia.
    Hussein E; Ahmed Eldesoukey N; Rihan A; Kamal A
    Arch Pathol Lab Med; 2014 May; 138(5):684-8. PubMed ID: 24786127
    [TBL] [Abstract][Full Text] [Related]  

  • 59. High frequency of autoimmunization among transfusion-dependent Tunisian thalassaemia patients.
    Guirat-Dhouib N; Mezri M; Hmida H; Mellouli F; Kaabi H; Ouderni M; Zouari B; Hmida S; Bejaoui M
    Transfus Apher Sci; 2011 Oct; 45(2):199-202. PubMed ID: 21889408
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Red Cell Alloimmunization In Multitransfused Thalassaemia Major Patients.
    Moeen S; Farooq N; Irshad R; Ashfaq M; Farooq U; Idris M
    J Ayub Med Coll Abbottabad; 2018; 30(1):81-84. PubMed ID: 29504337
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.